Actively Recruiting
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
Led by Well- Konnect Healthcare Services and Research Firm · Updated on 2024-11-27
100
Participants Needed
1
Research Sites
343 weeks
Total Duration
On this page
Sponsors
W
Well- Konnect Healthcare Services and Research Firm
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms. The symptoms of long COVID can include extreme tiredness (fatigue), shortness of breath, memory and concentration issues (brain fog), heart palpitations, dizziness, joint pain, muscle aches, cough, headaches, anxiety, and depression. It's important to note that there are various other symptoms that individuals can experience after a COVID-19 infection, such as loss of smell, chest pain or tightness, difficulty sleeping (insomnia), pins and needles, depression, anxiety, tinnitus, earaches, nausea, diarrhea, stomach aches, loss of appetite, cough, headaches, sore throat, and changes to the sense of smell or taste. To be included in the study, participants must have had symptoms for more than 4 weeks. The goal of the study is to measure biomarkers, identify new ones through clinical trials, and individualize and optimize treatment plans, which may or may not include COVID-19 post-market antivirals, vaccines, and medical care. It's essential to conduct thorough clinical trials to understand the long-term effects of COVID-19 and to develop personalized treatment plans for individuals experiencing long-haul symptoms.
CONDITIONS
Official Title
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Inclusion of Men, Women, and Minorities
- Participants must be at least 18 years old
- Participants must have a positive COVID-19 diagnosis or clinical diagnosis of COVID-19
- Participants must have experienced persistent symptoms after recovering from the acute phase of the illness
- Participants must be willing to provide informed consent to participate in the study
- Participants must be able to communicate effectively in English or have a translator available
- Participants must be able to attend follow-up appointments as required by the study protocol
- Participants must not have any medical conditions or take any medications that could interfere with the study results
You will not qualify if you...
- Older than 65 years of age
- Medical history of myocarditis
- Medical history of pericarditis
- Medical history of severe renal impairment with eGFR less than 30 mL/min
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NIH Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
K
Kawana J Williams, Ph.D.
CONTACT
K
KENNY WILLIAMS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here